MEA Diagnostic Catheter Market

MEA Diagnostic Catheter Market Size (2022 to 2027)

The Middle East & Africa Diagnostic Catheter Market size was calculated at USD 0.30 Million in 2022. This value is further estimated to be growing at a CAGR of 7.2% and worth USD 0.42 million by 2027, as per the recent research report published by Market Data Forecast.

Catheters are thin tubes made of medical grade material such as plastic, silicon rubber, polyvinyl chloride (PVC). Catheterization is a primary co-procedure performed with varied other medical procedures such as angioplasty, cardiac electrophysiology, and neurosurgery, wherein catheters are used.

The Market is expected to witness moderate growth during the forecast period, owing to the rise in the number of surgeries and the high demand for minimally invasive procedures. Also, an increase in the geriatric population base and a rise in demand for sterile & disposable catheters supplement the market growth. Furthermore, the increase in reimbursement levels and catheter technology advancements is expected to boost market growth.

However, inadequate quality assurance and price competition at domestic levels are expected to hamper this growth.

This research report on the Middle East and Africa Diagnostic Catheter Market has been segmented and sub-segmented into the following categories.

By Type: 

• Imaging catheters
• Non-imaging catheters

By Application: 

• Neurology
• Urology
• Gastroenterology
• Cardiology
• Others (Bronchoscopy and Gynecology)

By End-user: 

• Hospitals
• Imaging & Diagnostic Centers

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Companies playing a progressing role in the MEA Diagnostic Catheter Market profiled in this report are Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic plc (Ireland), Johnson & Johnson (U.S.), Koninklijke Philips N.V. (Netherlands), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Cardinal Health, Inc. (U.S.), Edward Lifesciences Corporation (U.S.), and Terumo Corporation (Japan).